In APP transgenic mice specifically overexpressing TFEB in hippocampal astrocytes, TFEB mainly localizes in the nuclei of astrocytes and enhances lysosome function, resulting in reduced Aβ levels and amyloid plaque load. The gene discussed is APP; the disease is amyloidosis.